Annals of Emergency Medicine
Volume 37, Issue 3 , Pages 251-258 , March 2001

Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department

Presented in part at the American College of Emergency Physicians Research Forum, Philadelphia, PA, October 2000.

Received 1 May 2000 ,Revised 22 November 2000 ,Accepted 15 December 2000.

References 

  1. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest. 1992;102:408S–425S
  2. Hovanessian HC. New-generation anticoagulants: the low molecular weight heparins. Ann Emerg Med. 1999;34:768–779
  3. Weitz JI. Low-molecular-weight heparins [Published erratum in N Engl J Med. 1997;337:1567.]. N Engl J Med. 1997;337:688–698
  4. Dolovich LR, Ginsberg JS, Douketis JD, et al.  A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med. 2000;160:181–188
  5. Van den Belt AG, Prins MH, Lensing AW, et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism [Cochrane Review]. Cochrane Database Syst Rev. 2000; CD001100
  6. Koopman MM, Prandoni P, Piovella F, et al.  Treatment of thrombosis with intravenous unfractionated heparin administered in the hospital with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996;334:682–687
  7. Levine M, Gent M, Hirsh J, et al.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:677–681
  8. The Columbus Investigators . Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med. 1997;337:657–662
  9. O’Brien B, Levine M, Willan A, et al.  Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med. 1999;159:2298–2304
  10. Bossuyt PM, Van den Belt AG, Prins MH. Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients’ quality of life. Hemostasis. 1998;28:100–107
  11. Harrison L, McGinnis J, Crowther M, et al.  Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med. 1998;158:2001–2003
  12. Estrada CA, Mansfield CJ, Heudebert GR. Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis. J Gen Intern Med. 2000;15:108–115
  13. Gould MK, Dembitzer AD, Sanders GD, et al.  Low-molecular-weight heparins compared with unfractionated heparin for treatment of deep venous thrombosis: a cost-effectiveness analysis. Ann Intern Med. 1999;130:789–799
  14. Rodger M, Bredeson C, Well PS, et al.  Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. CMAJ. 1998;59:931–938
  15. Dunn AS, Coller B. Outpatient treatment of deep vein thrombosis: translating clinical trials into practice. Am J Med. 1999;106:660–669
  16. Innes GD, Dillon EC, Holmes A. Low-molecular-weight heparin in the emergency department treatment of venous thromboembolism. J Emerg Med. 1997;15:563–566
  17. Levine MN, Hirsh J, Landefeld S, et al.  Hemorrhagic complications of anticoagulant treatment. Chest. 1992;102(Suppl 4):352S–363S
  18. Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincials Hospital Trust; 1972;
  19. Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ. 1999;319:652–653
  20. Schafer AI. Low-molecular-weight heparin—an opportunity for home treatment of venous thromboembolism. N Engl J Med. 1996;334:724–725
  21. Wells PS, Kovacs MJ, Bormanis J, et al.  Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med. 1998;158:1809–1812
  22. Pearson SD, Blair R, Halpert A, et al.  An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin. Eff Clin Pract. 1999;2:210–217
  23. Hull RD, Raskob GE, Brant RF, et al.  Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. Arch Intern Med. 2000;160:229–236
  24. Kovacs MJ, Anderson D, Morrow B, et al.  Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost. 2000;83:209–211
  25. Meignan M, Rosso J, Gauthier H, et al.  Systematic lung scans reveal a high frequency of silent pulmonary emboli in patients with proximal deep venous thrombosis. Arch Intern Med. 2000;160:159–164
  26. Shegda LM, McCorkle R. Continuing care in the community. J Pain Symptom Manage. 1990;5:279–286
  27. Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983;249:1743–1745

☆ Address for reprints: David A. Berman, DO, Department of Emergency Medicine, Kaiser Permanente Medical Center, 1600 Eureka Road, Roseville, CA 95661; 916-784-5396, fax 916-784-5978; E-mail David.A.Berman@kp.org .

PII: S0196-0644(01)61382-9

doi: 10.1067/mem.2001.113703

Annals of Emergency Medicine
Volume 37, Issue 3 , Pages 251-258 , March 2001

Article Tools

* Image Usage & Resolution